MedPath

EMORY UNIVERSITY

EMORY UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1836-12-10
Employees
10K
Market Cap
-
Website
http://www.emory.edu

Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma (Asthma-Bariatric Surgery Study)

Completed
Conditions
Asthma
First Posted Date
2008-02-14
Last Posted Date
2013-07-31
Lead Sponsor
Emory University
Target Recruit Count
80
Registration Number
NCT00615498
Locations
🇺🇸

Emory University, Emory Crawford Long Hospital, Clinical Research Center, Atlanta, Georgia, United States

Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in Asthmatics

Completed
Conditions
Asthma
Interventions
Other: No intervention
First Posted Date
2008-02-14
Last Posted Date
2008-09-23
Lead Sponsor
Emory University
Target Recruit Count
300
Registration Number
NCT00615706
Locations
🇺🇸

Emory University, Emory Crawford Long Hospital, Clinical Research Center, Atlanta, Georgia, United States

TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients

Completed
Conditions
Hyperglycemia
First Posted Date
2008-01-30
Last Posted Date
2013-12-13
Lead Sponsor
Emory University
Target Recruit Count
170
Registration Number
NCT00604669
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD

Completed
Conditions
COPD
First Posted Date
2008-01-30
Last Posted Date
2013-11-21
Lead Sponsor
Emory University
Target Recruit Count
450
Registration Number
NCT00605007
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships

Not Applicable
Recruiting
Conditions
Suicide, Attempted
Battered Women
Interventions
Behavioral: Enhanced treatment as usual (ETAU)
Behavioral: Psychoeducational intervention (PEI)
First Posted Date
2008-01-28
Last Posted Date
2024-11-11
Lead Sponsor
Emory University
Target Recruit Count
397
Registration Number
NCT00601939
Locations
🇺🇸

Grady Hospital, Atlanta, Georgia, United States

Heart Failure Study: The Atlanta Cardiomyopathy Consortium

Completed
Conditions
Heart Failure
First Posted Date
2008-01-23
Last Posted Date
2015-11-01
Lead Sponsor
Emory University
Target Recruit Count
335
Registration Number
NCT00599014
Locations
🇺🇸

Center for Heart Failure at EUH Midtown, 4th Floor, 550 Peachtree Street, Atlanta, Georgia, United States

🇺🇸

The Emory Clinic, Bldg A., 2nd Floor, 1365 Clifton Road, NE, Atlanta, Georgia, United States

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery

Phase 4
Completed
Conditions
Inpatient Hyperglycemia
Type 2 Diabetes
Interventions
First Posted Date
2008-01-17
Last Posted Date
2014-03-12
Lead Sponsor
Emory University
Target Recruit Count
234
Registration Number
NCT00596687
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes

Phase 4
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: NPH insulin + regular insulin
First Posted Date
2008-01-10
Last Posted Date
2014-06-11
Lead Sponsor
Emory University
Target Recruit Count
130
Registration Number
NCT00590226
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

FFA-Induced Hypertension and Endothelial Dysfunction

Not Applicable
Completed
Conditions
Endothelial Dysfunction
Hypertension
Interventions
Dietary Supplement: 64-gram oral fat load
Drug: Normal Saline
Dietary Supplement: 32-gram oral fat load
First Posted Date
2008-01-10
Last Posted Date
2018-10-16
Lead Sponsor
Emory University
Target Recruit Count
13
Registration Number
NCT00589888
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

Phase 4
Completed
Conditions
Diabetic Ketoacidosis
Interventions
Drug: insulin glargine+ glulisine
Drug: NPH + Regular insulin
First Posted Date
2008-01-10
Last Posted Date
2018-09-26
Lead Sponsor
Emory University
Target Recruit Count
74
Registration Number
NCT00590044
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

🇺🇸

University of Minnesota School of Medicine, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath